This microcredential is a core module on the MSc Clinical Oncology programme, an optional module on the MRes Cancer Sciences programme and can also be taken on a stand-alone basis for CPD purposes.
Microcredential overview
The module will focus on diagnosis of cancer with an emphasis on molecular testing and the role of histopathology in the stratification of cancer patients. It will compare and contrast traditional histopathological evaluation with molecular testing as prognostic and predictive markers. The module will also highlight new technologies, especially in Next Generation Sequencing, and will consider how these are already impacting on routine diagnostic histopathology.
Attendance required
One week block of teaching plus exam to follow.
Academics involved in the delivery of this module
Professor Paul Murray, Institute of Cancer and Genomic Sciences.
This course is available without the assessment/credits if preferred.
Prerequisites
2:1 degree
For further information please contact:
Programme Administrator
Tel: +44 (0)121 414 7672
Email: clinicaloncology@contacts.bham.ac.uk